Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Lung Carcinogenesis
90%
Small Molecules
65%
In Cancer
59%
Tumor Progression
59%
ERK Pathway
56%
Cancer Therapy
56%
BRAF V600E
54%
Melanoma
54%
Ubiquitination
53%
Phosphoinositide 3-kinase (PI3K)
50%
Esophageal Cancer
45%
Aurora Kinase A (AURKA)
45%
Sex-determining Region Y-box 2 (SOX2)
45%
Drug Resistance
45%
4-Hydroxyderricin
45%
Xanthoangelol
45%
Cancer Mechanisms
45%
Transcription Factor
45%
Cyclin-dependent Kinase 1 (CDK1)
45%
Prostaglandin Pathway
45%
Chromosome Condensation
45%
Ashitaba
45%
Lung Adenocarcinoma
45%
Angelica Keiskei
45%
MEK-ERK Pathway
45%
Melanopsin
45%
Reductase
45%
Chalcone
45%
Fluvastatin
45%
3-hydroxy-3-methylglutaryl-coenzyme A
45%
Melanomagenesis
45%
Protector
45%
Barrett's Esophagus
45%
Colorectal Tumorigenesis
45%
Cancer Prevention
45%
Thromboxane A2 (TXA2)
45%
Wilms Tumor
45%
Esophageal Adenocarcinoma
45%
Disease-associated
45%
Inflammatory Bowel Disease
45%
Esophageal Squamous Cell Carcinoma
45%
Cyclooxygenase-1 (COX-1)
45%
Glycogen Synthase Kinase 3 (GSK3)
45%
Cancer Growth
45%
Opsin
40%
HMG-CoA Reductase
36%
Prostaglandins
35%
Phosphorylation
35%
Tumorigenesis
34%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
99%
Melanoma
90%
Carcinogenesis
78%
Lung Adenocarcinoma
54%
Non Small Cell Lung Cancer
45%
Transcription Factor Sox2
45%
Chalcone Derivative
45%
Esophagus Cancer
45%
HMG-CoA
45%
Prostaglandin
45%
Oxidoreductase
45%
Lung Carcinogenesis
45%
Aurora B Kinase
45%
Drug Resistance
45%
Fluindostatin
45%
Melanopsin
45%
Angelica
45%
Opsin
40%
Hydroxymethylglutaryl Coenzyme A Reductase
36%
Lung Cancer
32%
Neoplasm
32%
Cyclin Dependent Kinase
22%
Survival Rate
18%
Cancer Growth
18%
Prostaglandin Receptor
18%
Tumor Growth
18%
Mouse Model
15%
Protein Kinase B
15%
Cycline
15%
Esophagus Tumor
14%
Knockout Mouse
14%
Lung Tumor
13%
Vemurafenib
9%
Mitogen Activated Protein Kinase 3
9%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
9%
NNK
9%
Mevalonic Acid
9%
Cancer Incidence
9%
Tumor Model
9%
Prostaglandin Synthase
9%
Receptor
9%
Wild Type Mouse
7%
Transcription Factors
7%
Protein Serine Threonine Kinase
7%
Proteasome
7%
Clinical Trial
7%
Preclinical Study
7%
Carcinogenicity
7%
Multiple Cancer
7%
Medicine and Dentistry
Melanoma
90%
Lung Carcinogenesis
45%
Transcription Factor Sox2
45%
Chromosome Condensation
45%
Chalcone Derivative
45%
Esophageal Cancer
45%
Angelica
45%
Thromboxane A2
45%
Esophageal Adenocarcinoma
45%
Aurora B Kinase
45%
Drug Resistance
45%
Fibrinogen
45%
Barrett Esophagus
45%
Programmed Cell Death
28%
Lung Cancer
28%
Cell Signaling Pathway
23%
Neoplasm
21%
Protein Kinase B
17%
Acetylsalicylic Acid
12%
Cancer Cell
11%
Cell Cycle Checkpoint
11%
Therapeutic Agent
11%
Cell Cycle Progression
11%
Hope
11%
G1 Phase
11%
Cancer Incidence
11%
Melanoma Cell
11%
Cell Cycle Arrest
11%
Vemurafenib
9%
In Vitro
9%
Ubiquitination
9%
Survival Rate
8%
Esophagus Tumor
7%
Cell Proliferation
7%
Cancer
7%
Cell Growth Assay
6%
Anchorage
6%
Xenograft
6%
Cell Growth
6%
Esophagus Biopsy
6%
Synthetase
6%
Enzyme Immunoassay
6%
Biopsy Sample
6%
Cancer Therapy
5%
Urethan
5%
Tumor Invasion
5%
Proteus Syndrome
5%
Receptor Family
5%
Tumor Necrosis Factor Receptor Associated Factor 1
5%
Tumor Necrosis Factor Receptor Associated Factor 2
5%
